June 2018 FDA Recall Drug by Sca Pharmaceuticals
D-0918-2018 - Subpotent Drug

This Class II drug recall was voluntarily initiated by Sca Pharmaceuticals on June 29, 2018 for the product Drug. The FDA reported the reason for recall as subpotent drug. The product was distributed in United States and the recall is currently terminated.

Recall Number: D-0918-2018

Reason for Recall
Subpotent Drug: Stability data does not support the current expiration dating of 55 days after compounding.
Initiated
06-29-2018
Reported
07-18-2018
Quantity
3984 syringes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Buffered Lidocaine 1% with Sodium Bicarbonate Injection for Local Anesthetic Use (Concentration=10 mg/mL) 0.25 mL Total Volume, Rx only , SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205 877-550-5059

Batch or Lot Expiration Information

Lot# : 20180507@21, Exp 7/1/2018; 20180511@9, 20180511@24, Exp 7/5/2018; 20180518@24, 20180518@31, 20180518@32, Exp 7/12/2018; 20180531@21, Exp 7/25/2018; 20180601@11, Exp 7/26/2018